Your browser doesn't support javascript.
loading
Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
Iwamoto, Tomotada; Murase, Yoshiro; Yoshida, Shiomi; Aono, Akio; Kuroda, Makoto; Sekizuka, Tsuyoshi; Yamashita, Akifumi; Kato, Kengo; Takii, Takemasa; Arikawa, Kentaro; Kato, Seiya; Mitarai, Satoshi.
Afiliación
  • Iwamoto T; Department of Infectious Diseases, Kobe Institute of Health, Kobe City, Japan.
  • Murase Y; Bacteriology Division, Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose City, Tokyo, Japan.
  • Yoshida S; Clinical Research Center, National Hospital Organization Kinki-chuo Chest Medical Center, Sakai City, Osaka, Japan.
  • Aono A; Bacteriology Division, Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose City, Tokyo, Japan.
  • Kuroda M; Pathogen Genomics Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
  • Sekizuka T; Pathogen Genomics Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
  • Yamashita A; Pathogen Genomics Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
  • Kato K; Pathogen Genomics Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
  • Takii T; Molecular Epidemiology Division, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose City, Tokyo, Japan.
  • Arikawa K; Department of Infectious Diseases, Kobe Institute of Health, Kobe City, Japan.
  • Kato S; Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose City, Tokyo, Japan.
  • Mitarai S; Bacteriology Division, Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose City, Tokyo, Japan.
PLoS One ; 14(2): e0212798, 2019.
Article en En | MEDLINE | ID: mdl-30817803
ABSTRACT

OBJECTIVES:

Automated online software tools that analyse whole genome sequencing (WGS) data without the need for bioinformatics expertise can motivate the implementation of WGS-based molecular drug susceptibility testing (DST) in routine diagnostic settings for tuberculosis (TB). Pyrazinamide (PZA) is a key drug for current and future TB treatment regimens; however, it was reported that predictive power for PZA resistance by the available tools is low. Therefore, this low predictive power may make users hesitant to use the tools. This study aimed to elucidate why and to uncover the real performance of the tools when taking into account their variation calling lists (manual inspection), not just their automated reporting system (default setting) that was evaluated by previous studies.

METHODS:

WGS data from 191 datasets comprising 108 PZA-resistant and 83 susceptible strains were used to evaluate the potential performance of the available online tools (TB Profiler, TGS-TB, PhyResSE, and CASTB) for predicting phenotypic PZA resistance.

RESULTS:

When taking into consideration the variation calling lists, 73 variants in total (47 non-synonymous mutations and 26 indels) in pncA were detected by TGS-TB and PhyResSE, covering all mutations for the 108 PZA-resistant strains. The 73 variants were confirmed by Sanger sequencing. TB Profiler also detected all but three complete loss, two large deletion at the 3'-end, and one relatively large insertion of pncA. On the other hand, many of the 73 variants were lacking in the automated reporting systems except by TGS-TB; of these variants, CASTB detected only 20. By applying the 'non-wild type sequence' approach for predicting PZA resistance, accuracy of the results significantly improved compared with that of the automated results obtained by each tool.

CONCLUSION:

Users can obtain more accurate predictions for PZA resistance than previously reported by manually checking the results and applying the 'non-wild type sequence' approach.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazinamida / Biología Computacional / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Evaluation_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazinamida / Biología Computacional / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Evaluation_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article